AKT1 and Insulin resistance: All of these genes were significantly upregulated after VT treatment, suggesting that VT downregulated serum insulin levels but increased insulin sensitivity and improved insulin resistance via the Irs/Akt/Mtor signaling pathway, which clarified the results of the ITT, QUICKI, and HOMA-IR at the genetic level.